AnGes, Inc. (TYO:4563)
Japan flag Japan · Delayed Price · Currency is JPY
60.00
+1.00 (1.67%)
Jul 17, 2025, 10:49 AM JST

AnGes Company Description

AnGes, Inc. engages in the research and development of gene-based medical products.

It develops HGF gene therapy product for the treatment of ischemic diseases; NF-κB Decoy Oligo DNA for chronic discogenic lumber back pain; and DNA vaccines for the treatment of hypertension and cervical intraepithelial neoplasia, as well as intranasal formulation of the COVID-19 vaccine.

The company was formerly known as AnGes MG, Inc. and changed its name to AnGes, Inc. in July 2017. AnGes, Inc. was incorporated in 1999 and is headquartered in Ibaraki, Japan.

AnGes, Inc.
CountryJapan
Founded1999
IndustryBiotechnology
SectorHealthcare
Employees55
CEOEi Yamada

Contact Details

Address:
Saito Bio-Incubator
Ibaraki, 567-0085
Japan
Websiteanges.co.jp

Stock Details

Ticker Symbol4563
ExchangeTokyo Stock Exchange
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyJPY
ISIN NumberJP3127700007
SIC Code2834

Key Executives

NamePosition
Ei YamadaChief Executive Officer